219 related articles for article (PubMed ID: 19443658)
21. The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10.
Archangelo LF; Gläsner J; Krause A; Bohlander SK
Oncogene; 2006 Jul; 25(29):4099-109. PubMed ID: 16491119
[TBL] [Abstract][Full Text] [Related]
22. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D
Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747
[TBL] [Abstract][Full Text] [Related]
23. The clathrin-binding domain of CALM-AF10 alters the phenotype of myeloid neoplasms in mice.
Stoddart A; Tennant TR; Fernald AA; Anastasi J; Brodsky FM; Le Beau MM
Oncogene; 2012 Jan; 31(4):494-506. PubMed ID: 21706055
[TBL] [Abstract][Full Text] [Related]
24. Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes.
Chang MJ; Wu H; Achille NJ; Reisenauer MR; Chou CW; Zeleznik-Le NJ; Hemenway CS; Zhang W
Cancer Res; 2010 Dec; 70(24):10234-42. PubMed ID: 21159644
[TBL] [Abstract][Full Text] [Related]
25. CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12.
Mulaw MA; Krause A; Deshpande AJ; Krause LF; Rouhi A; La Starza R; Borkhardt A; Buske C; Mecucci C; Ludwig WD; Lottaz C; Bohlander SK
Leukemia; 2012 May; 26(5):1012-9. PubMed ID: 22064352
[TBL] [Abstract][Full Text] [Related]
26. Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice.
Caudell D; Zhang Z; Chung YJ; Aplan PD
Cancer Res; 2007 Sep; 67(17):8022-31. PubMed ID: 17804713
[TBL] [Abstract][Full Text] [Related]
27. t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines.
Shibuya N; Taki T; Mugishima H; Chin M; Tsuchida M; Sako M; Kawa K; Ishii E; Miura I; Yanagisawa M; Hayashi Y
Genes Chromosomes Cancer; 2001 Sep; 32(1):1-10. PubMed ID: 11477655
[TBL] [Abstract][Full Text] [Related]
28. MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.
Kerry J; Godfrey L; Repapi E; Tapia M; Blackledge NP; Ma H; Ballabio E; O'Byrne S; Ponthan F; Heidenreich O; Roy A; Roberts I; Konopleva M; Klose RJ; Geng H; Milne TA
Cell Rep; 2017 Jan; 18(2):482-495. PubMed ID: 28076791
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1.
Barbosa K; Deshpande A; Chen BR; Ghosh A; Sun Y; Dutta S; Weetall M; Dixon J; Armstrong SA; Bohlander SK; Deshpande AJ
Exp Hematol; 2019 Jun; 74():42-51.e3. PubMed ID: 31022428
[TBL] [Abstract][Full Text] [Related]
30. Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice.
Caudell D; Harper DP; Novak RL; Pierce RM; Slape C; Wolff L; Aplan PD
Blood; 2010 Feb; 115(6):1194-203. PubMed ID: 20007546
[TBL] [Abstract][Full Text] [Related]
31. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
[TBL] [Abstract][Full Text] [Related]
32. AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylation.
Uğurlu-Çimen D; Odluyurt D; Sevinç K; Özkan-Küçük NE; Özçimen B; Demirtaş D; Enüstün E; Aztekin C; Philpott M; Oppermann U; Özlü N; Önder TT
Epigenetics Chromatin; 2021 Jul; 14(1):32. PubMed ID: 34215314
[TBL] [Abstract][Full Text] [Related]
33. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes.
Dik WA; Brahim W; Braun C; Asnafi V; Dastugue N; Bernard OA; van Dongen JJ; Langerak AW; Macintyre EA; Delabesse E
Leukemia; 2005 Nov; 19(11):1948-57. PubMed ID: 16107895
[TBL] [Abstract][Full Text] [Related]
34. Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged Leukemia.
Barve A; Vega A; Shah PP; Ghare S; Casson L; Wunderlich M; Siskind LJ; Beverly LJ
Cells; 2019 Oct; 8(11):. PubMed ID: 31717699
[TBL] [Abstract][Full Text] [Related]
35. DOTting the path to doom: how acceleration of histone methylation leads to leukemia.
Bach C; Slany RK
Cancer Cell; 2014 Dec; 26(6):781-782. PubMed ID: 25490442
[TBL] [Abstract][Full Text] [Related]
36. The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia models.
Dutta S; Krause A; Vosberg S; Herold T; Ksienzyk B; Quintanilla-Martinez L; Tizazu B; Chopra M; Graf A; Krebs S; Blum H; Greif PA; Vetter A; Metzeler K; Rothenberg-Thurley M; Schneider MR; Dahlhoff M; Spiekermann K; Zimber-Strobl U; Wolf E; Bohlander SK
Leukemia; 2016 May; 30(5):1166-76. PubMed ID: 26686248
[TBL] [Abstract][Full Text] [Related]
37. The MLL recombinome of acute leukemias.
Meyer C; Schneider B; Jakob S; Strehl S; Attarbaschi A; Schnittger S; Schoch C; Jansen MW; van Dongen JJ; den Boer ML; Pieters R; Ennas MG; Angelucci E; Koehl U; Greil J; Griesinger F; Zur Stadt U; Eckert C; Szczepański T; Niggli FK; Schäfer BW; Kempski H; Brady HJ; Zuna J; Trka J; Nigro LL; Biondi A; Delabesse E; Macintyre E; Stanulla M; Schrappe M; Haas OA; Burmeister T; Dingermann T; Klingebiel T; Marschalek R
Leukemia; 2006 May; 20(5):777-84. PubMed ID: 16511515
[TBL] [Abstract][Full Text] [Related]
38. Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond.
Chen CW; Armstrong SA
Exp Hematol; 2015 Aug; 43(8):673-84. PubMed ID: 26118503
[TBL] [Abstract][Full Text] [Related]
39. Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10-CALM and CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14-q21) suggests a potential role for truncated AF10 polypeptides.
Silliman CC; McGavran L; Wei Q; Miller LA; Li S; Hunger SP
Leukemia; 1998 Sep; 12(9):1404-10. PubMed ID: 9737689
[TBL] [Abstract][Full Text] [Related]
40. DOT1L-mediated H3K79 methylation in chromatin is dispensable for Wnt pathway-specific and other intestinal epithelial functions.
Ho LL; Sinha A; Verzi M; Bernt KM; Armstrong SA; Shivdasani RA
Mol Cell Biol; 2013 May; 33(9):1735-45. PubMed ID: 23428873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]